• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BridgeBio Oncology Therapeutics, Inc. - Common Stock (NQ:BBOT)

    13.30 +1.20 (+9.92%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 760,181
    Open 12.20
    Bid (Size) 13.05 (300)
    Ask (Size) 13.50 (100)
    Prev. Close 12.10
    Today's Range 12.20 - 13.50
    52wk Range 10.26 - 14.87
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗
    Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +8.2%
    +8.2%
    1 Month
    +6.1%
    +6.1%
    3 Month
    +7.5%
    +7.5%
    6 Month
    +6.9%
    +6.9%
    1 Year
    +6.9%
    +6.9%

    More News

    Read More
    News headline image
    BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT to Participate in Upcoming December Investor Healthcare Conferences
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT to Participate in the Jefferies Global Healthcare Conference in London
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire
    News headline image
    BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    From TheRas, Inc. (d/b/a BBOT)
    Via GlobeNewswire

    Frequently Asked Questions

    Is BridgeBio Oncology Therapeutics, Inc. - Common Stock publicly traded?
    Yes, BridgeBio Oncology Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does BridgeBio Oncology Therapeutics, Inc. - Common Stock trade on?
    BridgeBio Oncology Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for BridgeBio Oncology Therapeutics, Inc. - Common Stock?
    The ticker symbol for BridgeBio Oncology Therapeutics, Inc. - Common Stock is BBOT on the Nasdaq Stock Market
    What is the current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock?
    The current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock is 13.30
    When was BridgeBio Oncology Therapeutics, Inc. - Common Stock last traded?
    The last trade of BridgeBio Oncology Therapeutics, Inc. - Common Stock was at 01/08/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.